Varenicline Completed Phase 4 Trials for Psychiatric Illness / Cessation, Smoking Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01623505Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling
NCT02351167Genetically Informed Smoking Cessation Trial